Skip to main content
SpringerLink
Log in

Dasatinib

Pulmonary arterial hypertension: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Patkowska E, et al. Reversible pulmonary arterial hypertension as a complication of dasatinib treatment, with efficacious and safe continuation of chronic myeloid leukaemia therapy with nilotinib. Hematologia 4: 76-83, No. 1, 2013 [Polish; summarised from an English abstract]. - Poland

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dasatinib. Reactions Weekly 1486, 13 (2014). https://doi.org/10.1007/s40278-014-8524-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-8524-x

Search

Navigation